Explore more publications!

Latest News

Labels On
FILTER THE FEED
Left-wing Center-left Neutral Public Broadcaster Gov't Institution Center-right Right-wing Pro-Government Gov't Propaganda Indeterminate
FILTER THE FEED
Source Label Filters

All labels are selected. Deselect any labels you want to hide from your feed.

Labels:

Left-wing
Center-left
Neutral
Public Broadcaster
Gov't Institution
Center-right
Right-wing
Pro-Government
Gov't Propaganda
Indeterminate
Ledger Appoints New Chief Financial Officer and Opens NYC Office to Scale U.S. Expansion

Ledger Appoints New Chief Financial Officer and Opens NYC Office to Scale U.S. Expansion

Bitcoin and Ethereum ETF Options Trading Unlocked as Final U.S. Exchanges Drop Contract Limits

Bitcoin and Ethereum ETF Options Trading Unlocked as Final U.S. Exchanges Drop Contract Limits

(LEAD) Seoul shares crash over 6 pct on escalating U.S.-Iran conflict

(LEAD) Seoul shares crash over 6 pct on escalating U.S.-Iran conflict

Iowa Capital Dispatch: War in Middle East causes further stress on U.S. farmers

Iowa Capital Dispatch: War in Middle East causes further stress on U.S. farmers

Here are the latest developments in the U.S.–Israel–Iran war on Monday as the conflict enters its twenty-fourth day.

Here are the latest developments in the U.S.–Israel–Iran war on Monday as the conflict enters its twenty-fourth day.

Faraday Future says U.S. SEC ended probe with no action, Reuters says

Dual citizens weigh Trump, taxes in decision to renounce U.S. citizenship

Dual citizens weigh Trump, taxes in decision to renounce U.S. citizenship

Seoul shares crash over 6 pct on escalating U.S.-Iran conflict

Seoul shares crash over 6 pct on escalating U.S.-Iran conflict

PANTHERx® Rare Selected by Rhythm Pharmaceuticals Inc. as the Exclusive U.S. Specialty Pharmacy for the Expanded Indication for IMCIVREE® (setmelanotide)

PANTHERx® Rare Selected by Rhythm Pharmaceuticals Inc. as the Exclusive U.S. Specialty Pharmacy for the Expanded Indication for IMCIVREE® (setmelanotide)

Sensex, Nifty plunge as Trump's ultimatum to Iran spooks investors

Sensex, Nifty plunge as Trump's ultimatum to Iran spooks investors

SoftBank plans massive U.S. power plant for AI data centres

SoftBank plans massive U.S. power plant for AI data centres

Siemens Invests More Than $165 Million to Expand Manufacturing Across the Carolinas, Supporting U.S. Data Center Growth

Why high-speed rail has yet to reach the U.S.—and is change coming?

Why high-speed rail has yet to reach the U.S.—and is change coming?

[News] Orion/Voltrek Embarks on $10M in EV Charging Deployments; More than 80 U.S. Installations Range from the Northeast to the Carolinas to California

[News] Orion/Voltrek Embarks on $10M in EV Charging Deployments; More than 80 U.S. Installations Range from the Northeast to the Carolinas to California

Galderma Receives U.S. FDA Approval for Restylane® Contour™ for the Correction of Temple Hollowing

Galderma Receives U.S. FDA Approval for Restylane® Contour™ for the Correction of Temple Hollowing

The CNN Fear & Greed Index increased due to ongoing conflicts. U.S. stocks closed lower, with Nasdaq down 2%, while energy and financial sectors gained.

The CNN Fear & Greed Index increased due to ongoing conflicts. U.S. stocks closed lower, with Nasdaq down 2%, while energy and financial sectors gained.

What changes SNAP is making in food buying in the U.S.

What changes SNAP is making in food buying in the U.S.

Latest round of China-U.S. talks reaffirm commitment to managing differences and bolstering global stability

Latest round of China-U.S. talks reaffirm commitment to managing differences and bolstering global stability

U.S territory turned tropical maternity ward has produced thousands of ‘American’…

U.S. Judge for now dismisses lawsuit by Sam Altman’s sister accusing OpenAI CEO of sexual abuse

U.S. Judge for now dismisses lawsuit by Sam Altman’s sister accusing OpenAI CEO of sexual abuse

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions